Nigeria: Breakup of NAFDAC?

By the end of 2020, it is expected that spending on pharmaceuticals in Africa will reach between USD 40 Billion to USD 65 Billion[1]. The African market is currently the second fastest growing pharmaceutical market after Asia, with an annual compound growth rate of 12.5%[2].  West Africa has both a large young population under 25 years of age and an increasingly ageing population over 60 years of age and is a key high growth market for pharmaceutical companies.  The initiative by the West African Drug Regulatory Authorities Network (WADRAN) and the Economic Community for West African States (ECOWAS) to create one drug regulatory authority should further enhance the region’s

Please click here to read full article.

NAFDAC